Femme Homme
- | Pays :
- Thailand
- Finland
- Mexico
- Les 6 autres...
- | Organes : -
- | Spécialités : -
Extrait
The aim of the present study is to investigate whether women taking a new combined oral contraceptive pill (SH T00658ID, estradiol valerate/dienogest) experience fewer hormone withdrawal-associated symptoms such as pelvic pain or headache during their monthly cycle compared to a commonly used contraceptive pill (Microgynon).
Critère d'inclusion
- Oral Contraceptive ,Headache ,Pelvic Pain